Patents by Inventor Dana Kupersmith

Dana Kupersmith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220262527
    Abstract: A system for identifying secondary effects of medications. The system may include one or more processors and a storage medium. The storage medium may stores instructions that configure the processors to perform operations. As configured, the processors may retrieve records associated with medications from servers. The processors may also extract machine readable content from records and identify portions that are associated with secondary effects of medications. Further, the processors may aggregate identified portions in a database, determine a level of evidence for records based on sources, associate records with metadata indicating the level of evidence; and generate index files mapping the markup language files, the metadata tags, and the medications. Moreover, the processor may receive search queries from a client, identify a subset of the records associated with medications in the query using index files, and transmit the identified subset ranked according to the level of evidence.
    Type: Application
    Filed: March 8, 2022
    Publication date: August 18, 2022
    Inventors: Mark Kupersmith, Dana Kupersmith, Karl Kieburtz, Thomas Michael Chester
  • Patent number: 11302450
    Abstract: A system for identifying secondary effects of medications. The system may include one or more processors and a storage medium. The storage medium may stores instructions that configure the processors to perform operations. As configured, the processors may retrieve records associated with medications from servers. The processors may also extract machine readable content from records and identify portions that are associated with secondary effects of medications. Further, the processors may aggregate identified portions in a database, determine a level of evidence for records based on sources, associate records with metadata indicating the level of evidence; and generate index files mapping the markup language files, the metadata tags, and the medications. Moreover, the processor may receive search queries from a client, identify a subset of the records associated with medications in the query using index files, and transmit the identified subset ranked according to the level of evidence.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: April 12, 2022
    Assignee: Safe Therapeutics, LLC
    Inventors: Mark Kupersmith, Dana Kupersmith, Karl Kieburtz, Thomas Michael Chester
  • Publication number: 20190304604
    Abstract: A system for identifying secondary effects of medications. The system may include one or more processors and a storage medium. The storage medium may stores instructions that configure the processors to perform operations. As configured, the processors may retrieve records associated with medications from servers. The processors may also extract machine readable content from records and identify portions that are associated with secondary effects of medications. Further, the processors may aggregate identified portions in a database, determine a level of evidence for records based on sources, associate records with metadata indicating the level of evidence; and generate index files mapping the markup language files, the metadata tags, and the medications. Moreover, the processor may receive search queries from a client, identify a subset of the records associated with medications in the query using index files, and transmit the identified subset ranked according to the level of evidence.
    Type: Application
    Filed: April 2, 2019
    Publication date: October 3, 2019
    Inventors: Mark Kupersmith, Dana Kupersmith, Karl Kieburtz, Thomas Michael Chester